We are live on ! Find out more
PG

Prostatis Group Portfolio holdings

AUM $429M
1-Year Est. Return 26.55%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+26.55%
3 Year Est. Return
+72.92%
5 Year Est. Return
+90.2%
10 Year Est. Return
AUM
$285M
AUM Growth
+$21.4M
Cap. Flow
+$15.2M
Cap. Flow %
5.33%
Top 10 Hldgs %
39.09%
Holding
159
New
24
Increased
61
Reduced
58
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
26
NVIDIA
NVDA
$5.56T
$2.97M 1.04%
24,069
+2,129
+10% +$215K
SDVY icon
27
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.5B
$2.94M 1.03%
86,735
+10,967
+14% +$369K
EWG icon
28
iShares MSCI Germany ETF
EWG
$1.8B
$2.83M 0.99%
92,549
-5,353
-5% -$167K
XLRE icon
29
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.27B
$2.79M 0.98%
+72,526
New +$2.73M
INDA icon
30
iShares MSCI India ETF
INDA
$6.75B
$2.75M 0.97%
+49,339
New +$2.61M
RSP icon
31
Invesco S&P 500 Equal Weight ETF
RSP
$99.6B
$2.74M 0.96%
16,686
-1,943
-10% -$320K
MSFT icon
32
Microsoft
MSFT
$3.71T
$2.71M 0.95%
6,071
-260
-4% -$110K
EWC icon
33
iShares MSCI Canada ETF
EWC
$6.9B
$2.69M 0.94%
72,607
-7,015
-9% -$264K
MCHI icon
34
iShares MSCI China ETF
MCHI
$6.33B
$2.57M 0.9%
60,940
-15,956
-21% -$686K
EWU icon
35
iShares MSCI United Kingdom ETF
EWU
$3.81B
$2.57M 0.9%
+73,621
New +$2.59M
RDVI icon
36
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
$3.75B
$2.51M 0.88%
107,419
+19,218
+22% +$454K
SOXX icon
37
iShares Semiconductor ETF
SOXX
$42.8B
$2.44M 0.86%
9,904
-7,699
-44% -$1.76M
BNDX icon
38
Vanguard Total International Bond ETF
BNDX
$82.2B
$2.36M 0.83%
48,447
-1,056
-2% -$51.4K
GCOW icon
39
Pacer Global Cash Cows Dividend ETF
GCOW
$3.56B
$2.32M 0.81%
68,884
+13,590
+25% +$470K
AMZN icon
40
Amazon
AMZN
$2.79T
$2.32M 0.81%
11,891
+4,895
+70% +$899K
FPE icon
41
First Trust Preferred Securities and Income ETF
FPE
$6.28B
$2.24M 0.79%
129,281
+15,404
+14% +$266K
VOO icon
42
Vanguard S&P 500 ETF
VOO
$1.03T
$2.22M 0.78%
4,441
-2,299
-34% -$1.11M
IGLD icon
43
FT Vest Gold Strategy Target Income ETF
IGLD
$581M
$2.2M 0.77%
109,944
+12,506
+13% +$251K
BLV icon
44
Vanguard Long-Term Bond ETF
BLV
$5.69B
$1.95M 0.69%
27,791
-159
-0.6% -$11.1K
NEE icon
45
NextEra Energy
NEE
$174B
$1.93M 0.68%
27,215
+2,315
+9% +$164K
HD icon
46
Home Depot
HD
$320B
$1.88M 0.66%
5,420
+232
+4% +$79.1K
CVX icon
47
Chevron
CVX
$409B
$1.73M 0.61%
10,972
-66
-0.6% -$10.5K
HYG icon
48
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$1.7M 0.6%
22,102
-1,479
-6% -$114K
UNH icon
49
UnitedHealth
UNH
$356B
$1.56M 0.55%
3,023
+286
+10% +$140K
XOM icon
50
ExxonMobil
XOM
$656B
$1.55M 0.54%
13,489
-267
-2% -$31.1K

Similar funds

Prostatis Group's Q2 2024 Portfolio in Review

As of Q2 2024, Prostatis Group held 159 positions worth $285M, up 8.1% from $264M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Prostatis Group deployed $15.2M of net new capital in Q2 2024, opening 24 new positions and adding to 61 existing holdings. Its largest new stake was First Trust Long/Short Equity ETF: 59,184 shares worth $3.74M.

By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 84% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $3.47M trimmed.

  • Prostatis Group's largest Q2 2024 buy was First Trust Long/Short Equity ETF: 59,184 shares worth $3.74M.
  • Prostatis Group added most to State Street Financial Select Sector SPDR ETF in Q2 2024, an estimated $7.32M increase.
  • Prostatis Group's biggest Q2 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $3.47M.
  • Prostatis Group fully exited Invesco S&P 500 High Beta ETF in Q2 2024, selling an estimated $4.54M.
  • Prostatis Group's ten largest holdings make up 39% of its $285M portfolio in Q2 2024.
  • Prostatis Group opened 24 new positions and closed 12 in Q2 2024.
  • Prostatis Group's portfolio value rose 8.1% quarter-over-quarter to $285M.

Based on Prostatis Group's 13F filing for Q2 2024, filed 21 Mar 2025.